N. Ak And S. Vatansever, "Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6, pp.1787-1791, 2021
Ak, N. And Vatansever, S. 2021. Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6 , 1787-1791.
Ak, N., & Vatansever, S., (2021). Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6, 1787-1791.
Ak, Naziye, And Sezai VATANSEVER. "Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6, 1787-1791, 2021
Ak, Naziye And Vatansever, Sezai. "Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6, pp.1787-1791, 2021
Ak, N. And Vatansever, S. (2021) . "Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.46, no.6, pp.1787-1791.
@article{article, author={Naziye AK And author={Sezai VATANSEVER}, title={Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2021, pages={1787-1791} }